...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: If BP buys Apabetalone,...
5
Nov 05, 2019 08:32AM
6
Nov 05, 2019 08:50AM
8
Nov 05, 2019 08:58AM
6
Nov 05, 2019 09:15AM
4
Nov 05, 2019 09:24AM
5
Nov 05, 2019 09:48AM
7
Nov 05, 2019 12:39PM
3
Nov 05, 2019 01:44PM
3
Nov 05, 2019 01:57PM
3
Nov 05, 2019 02:02PM
3
Nov 05, 2019 02:17PM
5
Nov 05, 2019 02:17PM
2
Nov 05, 2019 02:34PM
3
Nov 05, 2019 02:43PM
6
Nov 05, 2019 03:10PM
2
Nov 05, 2019 03:20PM
2
Nov 05, 2019 03:23PM
3
Nov 05, 2019 03:44PM
3
Nov 05, 2019 04:09PM
1
Nov 05, 2019 04:30PM

Let's also keep in mind that the RVX208 (Apebetalone) patent runs out in 2027 unless it was extended, which I'm not aware of. And it may take up to 2021 before it gets to market after FDA approval. So does a buyout of $5 billion make any sense?

Does the RVX208 patent cover CKD and Cognition and does it also runs out in 2027?
 
Does the RVX208 patent cover any other indication? 
 
Koo 

6
Nov 05, 2019 05:05PM
3
Nov 05, 2019 05:06PM
7
Nov 05, 2019 06:20PM
2
Nov 05, 2019 06:57PM
1
Nov 06, 2019 07:18AM
2
Nov 06, 2019 09:06AM
1
Nov 06, 2019 09:27AM
2
Nov 06, 2019 10:02AM
7
Nov 06, 2019 10:45AM
5
Nov 06, 2019 11:06AM
2
Nov 06, 2019 11:15AM
5
Nov 06, 2019 11:24AM
2
Nov 06, 2019 11:58AM
7
Nov 06, 2019 12:30PM
10
Nov 06, 2019 12:42PM
3
Nov 06, 2019 03:53PM
2
Nov 06, 2019 09:03PM
5
Nov 07, 2019 02:02AM
3
Nov 07, 2019 08:14AM
2
Nov 07, 2019 09:00AM
9
Nov 07, 2019 10:42AM
2
Nov 07, 2019 11:06AM
3
Nov 07, 2019 02:02PM
5
Nov 07, 2019 04:39PM
3
Nov 07, 2019 05:40PM
5
Nov 08, 2019 08:31AM
1
Nov 09, 2019 06:10PM
2
Nov 09, 2019 09:09PM
2
Nov 09, 2019 10:02PM
6
Nov 10, 2019 08:37AM
5
Nov 10, 2019 09:23AM
7
Nov 10, 2019 10:17AM
Share
New Message
Please login to post a reply